Your browser doesn't support javascript.
loading
Identification of ß-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions.
Gold, Ben; Zhang, Jun; Quezada, Landys Lopez; Roberts, Julia; Ling, Yan; Wood, Madeleine; Shinwari, Wasima; Goullieux, Laurent; Roubert, Christine; Fraisse, Laurent; Bacqué, Eric; Lagrange, Sophie; Filoche-Rommé, Bruno; Vieth, Michal; Hipskind, Philip A; Jungheim, Louis N; Aubé, Jeffrey; Scarry, Sarah M; McDonald, Stacey L; Li, Kelin; Perkowski, Andrew; Nguyen, Quyen; Dartois, Véronique; Zimmerman, Matthew; Olsen, David B; Young, Katherine; Bonnett, Shilah; Joerss, Douglas; Parish, Tanya; Boshoff, Helena I; Arora, Kriti; Barry, Clifton E; Guijarro, Laura; Anca, Sara; Rullas, Joaquín; Rodríguez-Salguero, Beatriz; Martínez-Martínez, Maria S; Porras-De Francisco, Esther; Cacho, Monica; Barros-Aguirre, David; Smith, Paul; Berthel, Steven J; Nathan, Carl; Bates, Robert H.
Afiliação
  • Gold B; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Zhang J; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Quezada LL; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Roberts J; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Ling Y; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Wood M; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Shinwari W; Department of Microbiology & Immunology, Weill Cornell Medicine, 413 East 69th Street, New York, New York 10021, United States.
  • Goullieux L; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.
  • Roubert C; Evotec (Lyon) SAS, 69007 Lyon, France.
  • Fraisse L; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.
  • Bacqué E; Evotec (Lyon) SAS, 69007 Lyon, France.
  • Lagrange S; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.
  • Filoche-Rommé B; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.
  • Vieth M; Evotec (Lyon) SAS, 69007 Lyon, France.
  • Hipskind PA; Sanofi, Infectious Diseases Therapeutic Area, 69280 Marcy l'Étoile, France.
  • Jungheim LN; Evotec (Lyon) SAS, 69007 Lyon, France.
  • Aubé J; Sanofi, Integrated Drug Discovery, 94400 Vitry sur Seine, France.
  • Scarry SM; Lilly Biotechnology Center, Eli Lilly and Company, 10290 Campus Point Dr, San Diego, California 92121, United States.
  • McDonald SL; Lilly Research Laboratories, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.
  • Li K; YourEncore, 20 North Meridian Street, Indianapolis, Indiana 46204, United States.
  • Perkowski A; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Nguyen Q; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Dartois V; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Zimmerman M; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Olsen DB; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Young K; Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
  • Bonnett S; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey 07103, United States.
  • Joerss D; Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey 07103, United States.
  • Parish T; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.
  • Boshoff HI; Merck & Co., Inc., Infectious Diseases, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States.
  • Arora K; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States.
  • Barry CE; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States.
  • Guijarro L; TB Discovery Research, Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, Washington 98102, United States.
  • Anca S; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Bethesda, Maryland 20892, United States.
  • Rullas J; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Bethesda, Maryland 20892, United States.
  • Rodríguez-Salguero B; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, Bethesda, Maryland 20892, United States.
  • Martínez-Martínez MS; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Porras-De Francisco E; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Cacho M; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Barros-Aguirre D; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Smith P; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Berthel SJ; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Nathan C; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
  • Bates RH; Global Health Pharma R&D, GlaxoSmithKline, Severo Ochoa 2, Tres Cantos, Madrid 28760, Spain.
ACS Infect Dis ; 8(3): 557-573, 2022 03 11.
Article em En | MEDLINE | ID: mdl-35192346
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Revista: ACS Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Mycobacterium tuberculosis Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals Idioma: En Revista: ACS Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos